| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Center for Global Health and Diseases and
Division of Pediatric Infectious Diseases, Case Western Reserve University, Cleveland, OH 44106;
Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia; and
Kenya Medical Research Institute, Kisian, Kenya
The C-terminal 19-kDa fragment of Plasmodium falciparum merozoite surface protein-1 (MSP-119) is a target of protective Abs against blood-stage infection and a leading candidate for inclusion in a human malaria vaccine. However, the precise role, relative importance, and mechanism of action of Abs that target this protein remain unclear. To examine the potential protective role of Abs to MSP-119 in individuals naturally exposed to malaria, we conducted a treatment time to infection study over a 10-wk period in 76 residents of a highland area of western Kenya during a malaria epidemic. These semi-immune individuals were not all equally susceptible to reinfection with P. falciparum following drug cure. Using a new neutralization assay based on transgenic P. falciparum expressing the P. chabaudi MSP-119 orthologue, individuals with high-level MSP-119-specific invasion-inhibitory Abs (>75th percentile) had a 66% reduction in the risk of blood-stage infection relative to others in the population (95% confidence interval, 3–88%). In contrast, high levels of MSP-119 IgG or IgG subclass Abs measured by enzyme immunoassay with six different recombinant MSP-119 Ags did not correlate with protection from infection. IgG Abs measured by serology and functional invasion-inhibitory activity did not correlate with each other. These findings implicate an important protective role for MSP-119-specific invasion inhibitory Abs in immunity to blood-stage P. falciparum infection, and suggest that the measurement of MSP-119 specific inhibitory Abs may serve as an accurate correlate of protection in clinical trials of MSP-1-based vaccines.
This article has been cited by other articles:
|
|
 |
|
  M. Hashizume, T. Terao, and N. Minakawa The Indian Ocean Dipole and malaria risk in the highlands of western Kenya PNAS, February 10, 2009; 106(6): 1857 - 1862. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. S. Noland, B. Hendel-Paterson, X. M. Min, A. M. Moormann, J. M. Vulule, D. L. Narum, D. E. Lanar, J. W. Kazura, and C. C. John Low Prevalence of Antibodies to Preerythrocytic but Not Blood-Stage Plasmodium falciparum Antigens in an Area of Unstable Malaria Transmission Compared to Prevalence in an Area of Stable Malaria Transmission Infect. Immun., December 1, 2008; 76(12): 5721 - 5728. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-P. Carralot, C. Lemmel, S. Stevanovic, and S. Pascolo Mass spectrometric identification of an HLA-A*0201 epitope from Plasmodium falciparum MSP-1 Int. Immunol., November 1, 2008; 20(11): 1451 - 1456. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Mlambo and N. Kumar Transgenic Rodent Plasmodium berghei Parasites as Tools for Assessment of Functional Immunogenicity and Optimization of Human Malaria Vaccines Eukaryot. Cell, November 1, 2008; 7(11): 1875 - 1879. [Full Text] [PDF]
|
|
|
|
 |
|
 F. Y. Zeyrek, A. Babaoglu, S. Demirel, D. D. Erdogan, M. Ak, M. Korkmaz, and C. Coban Analysis of Naturally Acquired Antibody Responses to the 19-kd C-Terminal Region of Merozoite Surface Protein-1 of Plasmodium vivax from Individuals in Sanliurfa, Turkey Am J Trop Med Hyg, May 1, 2008; 78(5): 729 - 732. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. H. A. Osier, G. Fegan, S. D. Polley, L. Murungi, F. Verra, K. K. A. Tetteh, B. Lowe, T. Mwangi, P. C. Bull, A. W. Thomas, et al. Breadth and Magnitude of Antibody Responses to Multiple Plasmodium falciparum Merozoite Antigens Are Associated with Protection from Clinical Malaria Infect. Immun., May 1, 2008; 76(5): 2240 - 2248. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. S. Bergmann-Leitner, E. H. Duncan, J. R. Burge, M. Spring, and E. Angov Miniaturization of a High-throughput pLDH-based Plasmodium falciparum Growth Inhibition Assay for Small Volume Samples from Preclinical and Clinical Vaccine Trials Am J Trop Med Hyg, March 1, 2008; 78(3): 468 - 471. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Bastos, M. da Silva-Nunes, R. S. Malafronte, E. H. E. Hoffmann, G. Wunderlich, S. L. Moraes, and M. U. Ferreira Antigenic Polymorphism and Naturally Acquired Antibodies to Plasmodium vivax Merozoite Surface Protein 1 in Rural Amazonians Clin. Vaccine Immunol., October 1, 2007; 14(10): 1249 - 1259. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. TAKALA, D. L. SMITH, M. A. THERA, D. COULIBALY, O. K. DOUMBO, and C. V. PLOWE RARE PLASMODIUM FALCIPARUM MEROZOITE SURFACE PROTEIN 1 19-KDA (MSP-119) HAPLOTYPES IDENTIFIED IN MALI USING HIGH-THROUGHPUT GENOTYPING METHODS Am J Trop Med Hyg, May 1, 2007; 76(5): 855 - 859. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Dent, I. Malhotra, P. Mungai, E. Muchiri, B. S. Crabb, J. W. Kazura, and C. L. King Prenatal Malaria Immune Experience Affects Acquisition of Plasmodium falciparum Merozoite Surface Protein-1 Invasion Inhibitory Antibodies during Infancy J. Immunol., November 15, 2006; 177(10): 7139 - 7145. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Singh, K. Miura, H. Zhou, O. Muratova, B. Keegan, A. Miles, L. B. Martin, A. J. Saul, L. H. Miller, and C. A. Long Immunity to Recombinant Plasmodium falciparum Merozoite Surface Protein 1 (MSP1): Protection in Aotus nancymai Monkeys Strongly Correlates with Anti-MSP1 Antibody Titer and In Vitro Parasite-Inhibitory Activity. Infect. Immun., August 1, 2006; 74(8): 4573 - 4580. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. E. M. Persson, C. T. Lee, K. Marsh, and J. G. Beeson Development and Optimization of High-Throughput Methods To Measure Plasmodium falciparum-Specific Growth Inhibitory Antibodies. J. Clin. Microbiol., May 1, 2006; 44(5): 1665 - 1673. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Mahajan, D. Jani, R. Chattopadhyay, R. Nagarkatti, H. Zheng, V. Majam, W. Weiss, S. Kumar, and D. Rathore Identification, Cloning, Expression, and Characterization of the Gene for Plasmodium knowlesi Surface Protein Containing an Altered Thrombospondin Repeat Domain Infect. Immun., September 1, 2005; 73(9): 5402 - 5409. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Drew, P. R. Sanders, and B. S. Crabb Plasmodium falciparum Merozoite Surface Protein 8 Is a Ring-Stage Membrane Protein That Localizes to the Parasitophorous Vacuole of Infected Erythrocytes Infect. Immun., July 1, 2005; 73(7): 3912 - 3922. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. MINAKAWA, S. MUNGA, F. ATIELI, E. MUSHINZIMANA, G. ZHOU, A. K. GITHEKO, and G. YAN SPATIAL DISTRIBUTION OF ANOPHELINE LARVAL HABITATS IN WESTERN KENYAN HIGHLANDS: EFFECTS OF LAND COVER TYPES AND TOPOGRAPHY Am J Trop Med Hyg, July 1, 2005; 73(1): 157 - 165. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. C. JOHN, A. M. MOORMANN, D. C. PREGIBON, P. O. SUMBA, M. M. MCHUGH, D. L. NARUM, D. E. LANAR, M. D. SCHLUCHTER, and J. W. KAZURA CORRELATION OF HIGH LEVELS OF ANTIBODIES TO MULTIPLE PRE-ERYTHROCYTIC PLASMODIUM FALCIPARUM ANTIGENS AND PROTECTION FROM INFECTION Am J Trop Med Hyg, July 1, 2005; 73(1): 222 - 228. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Malhotra, P. Mungai, E. Muchiri, J. Ouma, S. Sharma, J. W. Kazura, and C. L. King Distinct Th1- and Th2-Type Prenatal Cytokine Responses to Plasmodium falciparum Erythrocyte Invasion Ligands Infect. Immun., June 1, 2005; 73(6): 3462 - 3470. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. H. Corran, R. A. O'Donnell, J. Todd, C. Uthaipibull, A. A. Holder, B. S. Crabb, and E. M. Riley The Fine Specificity, but Not the Invasion Inhibitory Activity, of 19-Kilodalton Merozoite Surface Protein 1-Specific Antibodies Is Associated with Resistance to Malarial Parasitemia in a Cross-Sectional Survey in The Gambia Infect. Immun., October 1, 2004; 72(10): 6185 - 6189. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
